Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.
about
Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasAutologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasHigh-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignanciesBevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
P2860
Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Phase I and pharmacokinetic st ...... th advanced refractory tumors.
@en
Phase I and pharmacokinetic st ...... th advanced refractory tumors.
@nl
type
label
Phase I and pharmacokinetic st ...... th advanced refractory tumors.
@en
Phase I and pharmacokinetic st ...... th advanced refractory tumors.
@nl
prefLabel
Phase I and pharmacokinetic st ...... th advanced refractory tumors.
@en
Phase I and pharmacokinetic st ...... th advanced refractory tumors.
@nl
P2093
P50
P1476
Phase I and pharmacokinetic st ...... ith advanced refractory tumors
@en
P2093
Antonio Viúdez
Javier Pérez-Calvo
José Manuel Aramendía
José Rifón
Laura Zufia
Marta Moreno
Milagros Hernández
Onintza Sayar
Santiago Viteri
P304
P356
10.1016/J.BBMT.2007.07.008
P577
2007-09-07T00:00:00Z